Lingping Zhu,1,2 Zhiqun Shu,3 Xiaoming Sun2,3 1Department of General Practice, Shenzhen Longhua District Central Hospital, Shenzhen, People’s Republic of China; 2Department of General Practice, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China; 3Pudong Institute for Health Development, Shanghai, People’s Republic of China Background: The purpose of this study was to investigate the expression of different miRNAs in nonmetastatic and metastatic endometrial cancer Existing evidence indicates that there are many factors affecting the metastasis of endometrial cancer, and miRNAs play an unique role in many processes of endometiral cancer. Materials and methods: miRNA sequences were downloaded from Th...
Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are ...
Endometrial cancer is the most common gynecological malignancy and the fourth most common cancer in ...
Qian Chen,1 Xiaoyun Zeng,2 Dongping Huang,2 Xiaoqiang Qiu2 1Department of Research, Affiliated Tumor...
Endometrial cancer (EC) is the most common genital cancer in women with increasing death rates. MiRN...
Endometrial carcinoma (EC) is a hall mark of gynecological malignancies that usually affects women a...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
Endometrial cancer (EC) is the most common gynecological malignancy. Recent studies have uncovered m...
Objective: To investigate the differential expression of microRNA (miRNA) in patients with endometri...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
International audienceIntroduction: Endometrial cancer (EC) is the most important gynecological canc...
International audienceIntroduction: Endometrial cancer (EC) is the most important gynecological canc...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
Background Endometrial cancer (EC) is the most frequently diagnosed gynecological malignancy and the...
Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are ...
Endometrial cancer is the most common gynecological malignancy and the fourth most common cancer in ...
Qian Chen,1 Xiaoyun Zeng,2 Dongping Huang,2 Xiaoqiang Qiu2 1Department of Research, Affiliated Tumor...
Endometrial cancer (EC) is the most common genital cancer in women with increasing death rates. MiRN...
Endometrial carcinoma (EC) is a hall mark of gynecological malignancies that usually affects women a...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
Endometrial cancer (EC) is the most common gynecological malignancy. Recent studies have uncovered m...
Objective: To investigate the differential expression of microRNA (miRNA) in patients with endometri...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
International audienceIntroduction: Endometrial cancer (EC) is the most important gynecological canc...
International audienceIntroduction: Endometrial cancer (EC) is the most important gynecological canc...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
Endometrial cancer (EC) is a urogenital cancer affecting millions of post-menopausal women, globally...
Background Endometrial cancer (EC) is the most frequently diagnosed gynecological malignancy and the...
Endometrial cancer is a common malignant gynecological tumor, but there are few biomarkers that are ...
Endometrial cancer is the most common gynecological malignancy and the fourth most common cancer in ...
Qian Chen,1 Xiaoyun Zeng,2 Dongping Huang,2 Xiaoqiang Qiu2 1Department of Research, Affiliated Tumor...